← Back to Research Library

Valence Labs Research

AOD-9604

hGH-Fragment Research Peptide

Compound
AOD-9604
Category
Research Peptide
Available Variant
5mg
Research Status
Research Use Only

Overview

AOD-9604 is a modified C-terminal fragment of human growth hormone. Literature describes it as based on the hGH 177–191 region with an additional N-terminal tyrosine.

Research interest includes metabolic and lipid-signaling biology. Experimental and animal models have examined beta-adrenergic and lipolytic pathway questions. Those preclinical findings should not be turned into consumer weight-loss claims.

Research Areas

  • hGH-Fragment Characterization

    AOD-9604 is studied as a modified C-terminal fragment of human growth hormone in laboratory research, including in vitro metabolism work.

  • Metabolic / Lipid-Signaling Research

    Published experimental work has examined metabolic and lipid-signaling questions associated with this hGH fragment.

  • Experimental Beta-Adrenergic / Lipolytic Pathway Research

    Animal studies have examined lipid-metabolism questions, including work in obese mice and beta(3)-adrenergic-receptor knock-out mice. Those findings remain preclinical.

How It Is Being Studied

AOD-9604 has been examined in in vitro and animal models. Findings from mice or other experimental systems should not be interpreted as established human weight-loss or body-fat outcomes.

This page summarizes published research contexts and does not provide treatment, dosing, or consumer-use guidance.

Specifications

Catalog details for this product.

Product Name
AOD-9604
Category
Research Peptide
Variant
5mg
Form
Documentation pending
Storage
Documentation pending
Purity
Documentation pending
Intended Use
Laboratory research use only

Available Documentation

Documentation will appear here as records are published.

Available Product

AOD-9604

5mg

View Product →